About this document

Fulhold Pharma Investor Update March 2019 by topwine is a document available to read on EtoBox.

This document provides an investor update from Fulhold Pharma Ltd. regarding several areas of their business: 1) They have complied with administrators regarding funds in administration and expect to receive the remaining shares soon. 2) They are focusing FDA regulatory efforts on a wound gel and reclassifying their main compound as a "supramolecule" to avoid separate compound characterizations. 3) Their South African sales have declined but they have recouped some lost revenue and aim to return to pre

Author

topwine

Language

EN